M Laraba, SH Tachour,
H Belbache, N Boubekri… - Advances in Traditional …, 2022 - Springer
Doxorubicin (DOX) is a potent anticancer drug; its use has been limited by its hepatotoxicity,
which is due to free radicals generation. This work aims to investigate whether the n-butanol …